SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-04-072422
Filing Date
2004-04-28
Accepted
2004-04-28 17:28:39
Documents
3
Period of Report
2004-06-15
Effectiveness Date
2004-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 549234
2 GRAPHIC g16178g50o97.jpg GRAPHIC 7994
3 GRAPHIC g16178g58q08.jpg GRAPHIC 51508
  Complete submission text file 0001193125-04-072422.txt   610549
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26372 | Film No.: 04761675
SIC: 2834 Pharmaceutical Preparations